CDSCO approves Jardiance for treatment of adults with chronic kidney disease in India Ruchika Sharma14 Feb 2024 5:49 PM ISTMumbai: The national regulatory authority of India, the Central Drugs Standard Control Organisation (CDSCO), has approved Jardiance...
Eli Lilly-Boehringer Ingelheim Jardiance gets USFDA approval for adults with chronic kidney disease Ruchika Sharma23 Sept 2023 12:30 PM ISTRidgefield: Eli Lilly and Company and Boehringer Ingelheim have announced that the U.S. Food and Drug Administration (FDA) has approved Jardiance...
FDA Approves Empagliflozin for CKD treatment, regardless of diabetes status Dr. Kamal Kant Kohli23 Sept 2023 10:45 AM ISTThe US Food and Drug Administration has approved another SGLT2 Inhibitor Empagliflozin for treatment of CKD regardless of diabetes status.Jardiance®...
Boehringer Ingelheim latest to sue US over drug price negotiation plan Ruchika Sharma22 Aug 2023 3:00 PM ISTType 2 diabetes treatment Jardiance, which Boehringer shares with US drugmaker Eli Lilly, is considered among the most likely drugs to be chosen for...
Eli Lilly- Boehringer Ingelheim Jardiance gets European Commission nod to treat adults with CKD Ruchika Sharma26 July 2023 4:30 PM ISTIngelheim: The European Commission (EC) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),...
FDA approves new oral therapy for treatment of Type 2 Diabetes in children Dr. Kamal Kant Kohli22 Jun 2023 9:45 AM ISTUSA: The US Food and Drug Administration (FDA) has approved empagliflozin (Jardiance, Boehringer Ingelheim) and empagliflozin combined with metformin...
Eli Lilly-Boehringer Ingelheim bags USFDA nod for Type 2 diabetes drugs Jardiance, Synjardy for children Ruchika Sharma21 Jun 2023 4:30 PM ISTUnited States: The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly and partner Boehringer Ingelheim's drugs Jardiance and...
Eli Lilly-Boehringer's Jardiance for children with type 2 diabetes accepted by USFDA Ruchika Sharma10 March 2023 12:23 PM ISTIndianapolis: Boehringer Ingelheim and Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has accepted a...
FDA reviews Empagliflozin's potential for arresting progression of chronic kidney disease Dr. Kamal Kant Kohli25 Jan 2023 8:15 PM ISTUSA: Jardiance (empagliflozin) tablets have received the supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA)....
USFDA accepts supplemental New Drug Application for Jardiance for adults with chronic kidney disease: Eli Lilly Ruchika Sharma22 Jan 2023 12:00 PM ISTIndianapolis: The U.S. Food and Drug Administration (USFDA) has accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin)...
USFDA nod to Zydus Diabetes drug Empagliflozin Ruchika Sharma4 Aug 2022 3:45 PM ISTThe drug will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.
Boehringer Ingelheim's empagliflozin gets CDSCO nod for heart failure with preserved ejection fraction Medical Dialogues Bureau19 May 2022 4:19 PM ISTNew Delhi: Boehringer Ingelheim, one of the world's leading, research-driven pharmaceutical companies, has received approval from the Central Drugs...
